There are many reports and recommendations from companies like McKinsey and others suggesting various approaches and strategies to deal with “Social” data–one of the most significant areas generating interest as part of the “Big Data” hype.  Although many of these appear to target more consumer-oriented industries, such as retail, consumer goods, financial services etc, most of it is applicable to Pharma as well.

Pharma is slow to embrace social data given the regulatory environment, as well as the complex economic marketplace in which it operates, so lags behind other industries when it comes to technology adoption in general.  Now is the right time for Pharma to jump in and embrace the power of the social world. 


Read More...